MRNAModerna Inc
MRNA
Moderna Inc110,370
Mkt Cap
$17.99BVolume
10.23M52W High
$59.5552W Low
$22.28PE Ratio
-6.25MRNA Fundamentals
Price
$45.37Prev Close
$45.94Open
$46.6450D MA
$51.76Beta
1.34Avg. Volume
5.54MEPS (Annual)
-$7.25P/B
2.07Rev/Employee
$413,617.02$6,976.61
Poll
Earnings Recap
Moderna reiterates its plan to deliver up to 10% revenue growth and GAAP operating expense reductions in 2026, excluding a non-recurring litigation settlement charge. Moderna projects year-end cash and investments of $4.5 to $5.0 billion for 2026.
Bullish
Moderna achieved substantial revenue growth and cost reductions, securing European regulatory approvals for mNEXSPIKE and mCOMBRIAX. The company also advanced its oncology pipeline with positive Phase 2b melanoma data.
Bearish
Moderna reported a significant net loss of $(1.3) billion, impacted by litigation settlement expenses, and saw its cash and investments decrease to $7.5 billion due to operating losses and R&D.